Dolutegravir and lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48 weeks results of a pilot clinical trial (TRAPRO)

Simple item page
dc.contributor.authorRial, Diego
dc.contributor.authorMiguel, Rosa de
dc.contributor.authorDomínguez Domínguez, Lourdes
dc.contributor.authorMontejerano, R.
dc.contributor.authorEsteban Cantos, Andrés
dc.contributor.authorBisbal, Otilia
dc.contributor.authorStella Ascariz, Natalia
dc.contributor.authorAranguren Rivas, Paula
dc.contributor.authorBermejo Plaza, C.
dc.contributor.authorGarcía Álvarez, M.
dc.contributor.authorAlejos, Belén
dc.contributor.authorHernando Jeréz, María Asunción
dc.contributor.authorMayoral, M.
dc.contributor.authorCastro, J. M.
dc.contributor.authorMoreno, Víctor
dc.contributor.authorMartín Carbonero, Luz
dc.contributor.authorDelgado, Rafael
dc.contributor.authorRubio, Rafael
dc.contributor.authorPulido, Federico
dc.contributor.authorArribas, José R.
dc.date.accessioned2020-02-11T10:38:52Z
dc.date.available2020-02-11T10:38:52Z
dc.date.issued2019
dc.description.filiationUEMspa
dc.description.impact1.654 JCR (2019) Q4, 79/92 Infectious Diseasesspa
dc.description.impact0.317 SJR (2019) Q3, 83/128 Microbiology (medical)spa
dc.description.impactNo data IDR 2019spa
dc.description.sponsorshipPlan Nacional PI16-00678spa
dc.identifier.citationRial-Crestelo, D., de Miguel Buckley, R., Domínguez Domínguez, L., Montejerano, R., Esteban, A., Bisbal, O., Hernando Jerez, M. A., …Arribas, J. R. (2019). Dolutegravir and lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48 weeks results of a pilot clinical trial (TRAPRO). Enfermedades Infecciosas y Microbiología Clínica, 37(especial), 81-82. https://doi.org/10.1016/j.ebiom.2020.102779spa
dc.identifier.doi10.1016/j.ebiom.2020.102779spa
dc.identifier.issn0213-005X
dc.identifier.urihttp://hdl.handle.net/11268/8585
dc.language.isoengspa
dc.peerreviewedSispa
dc.rights.accessRightsrestricted accessspa
dc.subject.uemVIH (Virus)spa
dc.subject.uemFarmacologíaspa
dc.subject.unescoSidaspa
dc.subject.unescoFarmacologíaspa
dc.titleDolutegravir and lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48 weeks results of a pilot clinical trial (TRAPRO)spa
dc.typeconference posterspa
dspace.entity.typePublication
relation.isAuthorOfPublicationc5d9ddbc-f605-406e-8dc1-8386b2e030cd
relation.isAuthorOfPublication.latestForDiscoveryc5d9ddbc-f605-406e-8dc1-8386b2e030cd

Files

Collections

Área de Ciencias de la Salud